FDA advisers warn of more deaths if drug is relaunched.

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalArticleProfessional

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'FDA advisers warn of more deaths if drug is relaunched.'. Together they form a unique fingerprint.

Medicine & Life Sciences